Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
43.92
+1.41 (3.32%)
At close: Sep 26, 2025, 4:00 PM EDT
43.96
+0.04 (0.09%)
After-hours: Sep 26, 2025, 7:18 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $8.21 billion as of September 26, 2025. Its market cap has increased by 17.98% in one year.
Market Cap
8.21B
Enterprise Value
6.21B
1-Year Change
17.98%
Ranking
Category
Stock Price
$43.92
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $8.21B, an increase of 399.25%. That is a compound annual growth rate of 33.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 8.21B | 1.57% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |